Glanbia Nutritionals will release its CreaBev sports nutrition ingredient for beverages in the European market later this year.
According to Glanbia, the powdered CreaBev ingredient features a patent-pending encapsulation technology that facilitates a more soluble and stable creatine monohydrate, enabling the creation of high-performance beverages for the sports nutrition sector.
The company claims that one of the main issues when using creatine monohydrate in ready-to-drink (RTD) and ready-to-mix (RTM) formulations is that it has poor solubility in water, and is unstable due to its degradation to waste product creatinine.
A study cited by Glanbia claims that in neutral pH RTD products using standard creatine monohydrate, approximately 95% of standard creatine monohydrate will be converted to creatinine after 3 months, with only 5% creatine monohydrate remaining. By 12 months, 100% has completely been degraded.
However, Glanbia states that in CreaBev, 70% of creatine monohydrate remained after 12 months, with only 30% degradation to creatinine.
Additionally, Glanbia alleges that CreaBev does not crystalise when exposed to Ultra Heat Treatment (UHT) or precipitate like conventional forms of creatine monohydrate.
The ingredient will be on display at Food Ingredients Europe in December, and Tara Bane – European marketing manager at Glanbia Nutritionals – said: “As ever we are excited to be back at FiE this year, and we are looking forward to introducing CreaBev to the European market.”
© FoodBev Media Ltd 2024
